A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples